Imp Promont Pharma & Biotech
IMP PROMONT d.o.o. is a Slovenian engineering company founded in 1992 that designs and installs demanding mechanical systems (clean utilities, orbital welding, pipelines, HVAC) for pharmaceutical, biotech, medical, and energy enterprises, primarily in Slovenia and Central Europe.
- Company typePrivate
- Founded1992
- HeadquartersLjubljana Črnuče, Slovenia
- Headcount—
- GTM typeB2B
- OfferingServices
What Imp Promont Pharma & Biotech does
IMP PROMONT d.o.o. is a privately-held Slovenian engineering company founded in 1992 and headquartered in Ljubljana Črnuče, specializing in the design and implementation of demanding mechanical and technological installations for pharmaceutical, biotechnology, medical, energy, gas, oil, and chemical industries. Its core offerings comprise four pillars: Clean Utilities (systems for preparation and distribution of pure water PW, WFI, CS, clean gases, CIP units, and prefabricated assemblies with cGMP-compliant DQ/IQ/FAT/OQ qualifications); Project Development (conceptual, basic, and detailed design using BIM and 3D modeling, P&ID and layouts); Industrial Energetics (heating, cooling, plumbing, compressed air, steam, gas, fire protection, and boiler room installations); and Infrastructure Projects (pipelines in carbon steel, stainless steel, polyethylene, and ductile iron for water, steam, natural gas, oxygen, and nitrogen transport). The company also operates certified orbital welding services accredited to ISO 3834-2 with IWE-certified engineers meeting AWS 18.2 and ASME BPE MJ-3 quality standards.
The business model is project-based and quote-driven, with pricing customized to client scope; revenue is generated through one-time engineering and installation contracts plus ongoing qualification services. Go-to-market is direct enterprise field sales targeting regulated industrial buyers, supported by a company website (imp-pro-mont.si), trade fair participation, and dedicated contact channels for sales, design, and HR. Customer concentration spans 28+ named enterprise logos across pharmaceutical (Lek, Krka, Novartis), energy (Petrol, Energetika, Adriaplin), industrial manufacturing (Sij Acroni, Knauf, Goodyear Sava, Lumentum), medical (Belimed, Medex), and infrastructure/logistics (Plinovodi, Luka Koper, Fraport).
Strategic positioning is reinforced by ISO 3834-2 welding, ISO 45001 OHS, ISO 14001 environmental, SCC-VAZ 2021 contractor safety, and PED Module A2 pressure equipment certifications, alongside EU NextGenerationEU consortium participation in the HyBReED hydrogen/battery storage program (€4.77M total budget) and the HVAC FIL-AI predictive-algorithm project with LEK and METRONIK (€2.1M project, €999K EU subsidy). Operating geographies are formally limited to Slovenia, though multinational customers imply cross-border project execution in Central Europe.
Imp Promont Pharma & Biotech firmographics
Firmographics- Name
- Imp Promont Pharma & Biotech
- Legal name
- IMP PROMONT d.o.o.
- Website
- https://www.imp-pro-mont.si
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Short description
- IMP PROMONT d.o.o. is a Slovenian engineering company founded in 1992 that designs and installs demanding mechanical systems (clean utilities, orbital welding, pipelines, HVAC) for pharmaceutical, biotech, medical, and energy enterprises, primarily in Slovenia and Central Europe.
- Ownership category
- akta.pro rank
Where Imp Promont Pharma & Biotech is headquartered
LocationHeadquarters
- HQ city
- Ljubljana Črnuče
- HQ country
- Slovenia
- HQ region
- Europe
Offices1 record
Markets served
Imp Promont Pharma & Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Engineering and Design Services: Project planning services including conceptual design, basic design, detailed design, feasibility studies, and project documentation for industrial, pharmaceutical, hospital, business and public facilities. Services provided from first draft to completion.
- Infrastructure Pipeline Construction: Construction of all types of infrastructure pipelines for transport of various media (water, hot water, steam, natural gas, oxygen, nitrogen) in carbon steels, stainless steels, polyethylene, ductile iron. Includes pipeline facilities like compressor stations, reducing/metering stations, pumping stations, and boiler rooms.
- Clean Utilities Installation: Design and implementation of clean utilities systems for pharmaceutical, biotechnological and medical industries. Includes clean water systems (PW, WFI, CS), clean gases, prefabricated assemblies, CIP units, cleaning and passivation of stainless steel systems.
- Industrial Energy Installations: Implementation of heating, cooling, plumbing, sewage, compressed air, steam lines, gas installations, technological installations, fire protection systems, heat stations, refrigerating stations, steam boiler rooms, and pumping stations.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Imp Promont Pharma & Biotech product offering
Product offeringCore offering
IMP PROMONT d.o.o. is a Slovenian engineering company that designs and implements complex mechanical and technological installations for pharmaceutical, biotechnology, medical, energy, gas, oil, and chemical industries. The company delivers turnkey services from conceptual and detailed design through execution, including BIM-based 3D modeling, orbital welding, clean utility systems (PW, WFI, CS, clean gases), infrastructure pipeline construction, and cGMP-compliant qualification (DQ, IQ, FAT, OQ).
Product overview
Imp Promont is a leading Slovenian engineering company offering a comprehensive portfolio of services for pharmaceutical, biotechnological, and medical industries. The core offerings include Clean Utilities (systems for preparation and distribution of pure water PW, WFI, CS, clean gases, and prefabricated assemblies), Project Development/Mechanical Installation Planning (comprehensive design services using BIM approach), Industrial Energetics (installation services for various industrial plants), and Infrastructure Projects (construction of infrastructure pipelines). Supporting services include certified Orbital Welding Services (ISO 3834 accredited) and Qualifications and Start-ups Services (cGMP compliant DQ, IQ, FAT, OQ). The company provides complete engineering services from concept to execution, combining planning, implementation, and qualification in a single integrated offering.
Differentiator
Problem solved
Functional benefit
Products and services
- Clean Utilities Systems
Quantifiable outcome
- Highest quality orbital welding requirements achieved per AWS 18.2 or ASME BPE MJ-3 standards
- +1 more outcomes
Companies that use Imp Promont Pharma & Biotech
Customer profileNamed customers28 records
Segments5 records
Ideal customer profiles4 records
Imp Promont Pharma & Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Imp Promont Pharma & Biotech partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Kemijski inštitutcoreLead consortium partner in HyBReED RRI program (€4.77M total budget) focused on resilient chemical energy storage with hydrogen and batteries. Provides research leadership in chemical engineering.
- Institut Jožef StefancoreResearch consortium partner in HyBReED program contributing scientific expertise to hydrogen and battery energy storage development.
- MESSER SLOVENIJA d.o.o.minorHyBReED consortium partner specializing in technical gases production and distribution, contributing industry perspective for hydrogen technologies application.
- PETROL d.d.minorSlovenian energy company consortium partner in HyBReED program, contributing energy sector expertise and supporting hydrogen technology deployment in energy-intensive industries.
- LEK farmacevtska družba d.d.coreConsortium partner in HVAC FIL-AI project (2023-2025, €2.1M project value) focused on improving material and energy efficiency for pharmaceutical manufacturing conditions. LEK serves as end-user partner providing real-world pharmaceutical industry requirements.
- METRONIK d.o.o.coreConsortium partner in HVAC FIL-AI project contributing technological integration expertise for developing predictive algorithms and material innovations for HVAC systems in pharmaceutical applications.
Scale indicators5 records
Recent moves5 records
Expansion highlights6 records
Imp Promont Pharma & Biotech competitors and assessment
Company assessmentBroad incumbents
- Jacobs Solutions: Jacobs is a global professional services and engineering firm with a substantial life-sciences and advanced-facilities practice (formerly Jacobs Engineering + CH2M). Comparable to IMP PROMONT on pharma/advanced-manufacturing facility delivery, but operating at much larger scale and broader service mix.
- Bilfinger SE: Bilfinger is a European industrial services provider with deep process-industry and pharma footprint, offering engineering, maintenance, and energy-efficiency services across multiple verticals. Larger in scale and broader in scope than IMP PROMONT, but overlapping materially on industrial energetics, pipeline infrastructure, and pharma facility services in Central Europe.
- Fluor Corporation: Fluor is one of the largest global EPC firms with a long-standing life-sciences business unit delivering cGMP manufacturing facilities. Overlap with IMP PROMONT on pharma process and clean utility engineering, though Fluor serves at mega-project scale where IMP PROMONT is excluded by capitalization.
- Worley Limited: Worley is a global engineering and project-delivery firm focused on energy, chemicals, and resource industries. Comparable on industrial pipeline infrastructure and energy-systems engineering, overlapping with IMP PROMONT's infrastructure pipeline and industrial energetics units, but at far larger contract sizes.
- Petrofac Limited: Petrofac is an international service provider to the energy industry covering facility design, engineering, and operations across oil, gas, and increasingly renewables/hydrogen. Tangentially comparable on hydrogen and industrial-energy infrastructure that aligns with IMP PROMONT's HyBReED positioning.
- STRABAG / Züblin (Ed. Züblin AG): Ed. Züblin AG is a German construction and civil engineering firm with significant industrial and infrastructure pipeline expertise across Central Europe. Overlaps with IMP PROMONT on large-diameter pipeline construction, industrial energetics, and infrastructure delivery, but at much greater scale and geographic coverage.
Direct peers
- Exyte: Exyte (formerly M+W Group) is a global leader in high-tech facility engineering—cleanrooms, process utilities, and cGMP-compliant pharma/biotech manufacturing facilities. It is the clearest direct peer in pharmaceutical clean utilities, orbital-grade welding, and turnkey qualification services comparable to IMP PROMONT's core offering.
- CRB Group: CRB is an architecture, engineering, and construction firm dedicated to life sciences, delivering cGMP-compliant facility design and construction for pharma and biotech clients. Overlap with IMP PROMONT is concentrated in regulated-industry clean utility design, qualification, and process installation.
- Lindner Group: Lindner is a European specialist in cleanroom and pharma interior construction, including HVAC, clean media distribution, and turnkey controlled-environment facility delivery. Closely comparable to IMP PROMONT on pharma-grade mechanical installation and clean utility buildouts in regulated environments.
- Pharmaplan: Pharmaplan is a German engineering specialist focused on pharmaceutical facility design, clean media systems, and qualification services for sterile and aseptic production. Direct comparison with IMP PROMONT on cGMP project execution, orbital welding, and GMP-compliant documentation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Imp Promont Pharma & Biotech social profiles
Digital presenceImp Promont Pharma & Biotech compliance and trust
Trust signalCompliance5 records
Imp Promont Pharma & Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Imp Promont Pharma & Biotech leadership team
Management profileNumber of profiles
Imp Promont Pharma & Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Imp Promont Pharma & Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Imp Promont Pharma & Biotech
What does Imp Promont Pharma & Biotech do?
IMP PROMONT d.o.o. is a Slovenian engineering company that designs and implements complex mechanical and technological installations for pharmaceutical, biotechnology, medical, energy, gas, oil, and chemical industries. The company delivers turnkey services from conceptual and detailed design through execution, including BIM-based 3D modeling, orbital welding, clean utility systems (PW, WFI, CS, clean gases), infrastructure pipeline construction, and cGMP-compliant qualification (DQ, IQ, FAT, OQ).
Is Imp Promont Pharma & Biotech a public or private company?
Imp Promont Pharma & Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Imp Promont Pharma & Biotech founded?
Imp Promont Pharma & Biotech was founded in 1992.
Where is Imp Promont Pharma & Biotech based?
Imp Promont Pharma & Biotech is headquartered in Ljubljana Črnuče, Slovenia, in the Europe region.
How does Imp Promont Pharma & Biotech make money?
Four revenue lines are on record. Engineering and Design Services are the primary driver. The others are infrastructure Pipeline Construction, clean Utilities Installation and industrial Energy Installations.
Who are Imp Promont Pharma & Biotech's main competitors?
Broad incumbents on record are Jacobs Solutions, Bilfinger SE, Fluor Corporation, Worley Limited, Petrofac Limited and STRABAG / Züblin (Ed. Züblin AG). Direct peers are Exyte, CRB Group, Lindner Group and Pharmaplan.
Does Imp Promont Pharma & Biotech have an API?
No public API is recorded for Imp Promont Pharma & Biotech.